Synlogic has announced it has secured $40 million in series B financing. Synlogic, based in Cambridge, Mass., is a biopharmaceutical company focused on the development of a class of therapeutics, called synthetic...more
The Numbers - Venture financing activity in New England increased modestly in the fourth quarter of 2014, with Seed and B/Later round activity increasing by 40% and 26%, respectively, over Q3 2014. For the second...more
Overall financing activity in the second quarter of 2014 showed robust increases over the prior quarters. In Q2 2014, Cooley handled 87 deals representing over $1.5 billion of invested capital. Of particular note, the...more